Maya Kornowski Cohen Liron Sheena Yair Shafir Vered Yahalom Anat Gafter-Gvili Galia Spectre
10.1159/000514283
Acta Haematol
2021;144(6):678-682.
covid-19 caplacizumab immune thrombotic thrombocytopenic purpura sars-cov-2
NO-CC CODE
https://pubmed.ncbi.nlm.nih.gov/33895748/
COVID-19 / complications Purpura, Thrombotic Thrombocytopenic / diagnosis
COVID-19 / complications Purpura, Thrombotic Thrombocytopenic / diagnosis Case Reports ADAMTS13 Protein / metabolism COVID-19 / pathology COVID-19 / virology Female Hemoglobins / metabolism Humans Middle Aged Plasma Exchange Platelet Count Purpura, Thrombotic Thrombocytopenic / etiology Purpura, Thrombotic Thrombocytopenic / therapy Recurrence SARS-CoV-2 / isolation & purification Single-Domain Antibodies / therapeutic use Hemoglobins Single-Domain Antibodies caplacizumab hemoglobin B ADAMTS13 Protein ADAMTS13 protein, human
PMC8247821
33895748
An Early Unexpected Immune Thrombotic Thrombocytopenic Purpura Relapse Associated with SARS-CoV-2 Infection: A Case Report and Literature Review
2021